Century Therapeutics (IPSC) Enterprise Value (2020 - 2026)
Century Therapeutics (IPSC) reported Enterprise Value of -$134.8 million for Q1 2026, up 54.05% year-over-year from -$87.5 million in Q1 2025, and up 20.02% quarter-over-quarter from -$168.6 million in Q4 2025.
Century Therapeutics (IPSC) Enterprise Value (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Enterprise Value data on file, last reported at -$134.8 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$134.8 million, up 54.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$134.8 million (up 54.05% YoY), and the FY2025 annual result was -$168.6 million, up 10.96% from the prior year.
- Enterprise Value rose to -$134.8 million in Q1 2026 per IPSC's latest filing, from -$168.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$134.8 million in Q1 2026 and troughed at -$378.8 million in Q2 2022.
- A 5-year average of -$229.0 million and a median of -$196.4 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 58.71% in 2023, then plunged 52.78% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$315.5 million in 2022, then surged by 45.25% to -$172.7 million in 2023, then dropped by 9.58% to -$189.3 million in 2024, then increased by 10.96% to -$168.6 million in 2025, then climbed by 20.02% to -$134.8 million in 2026.
- Business Quant data shows IPSC's Enterprise Value at -$134.8 million in Q1 2026, -$168.6 million in Q4 2025, and -$204.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -134.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.80 Mn |
| Dec 31, 2025 | -168.55 Mn |
| Sep 30, 2025 | -204.20 Mn |
| Jun 30, 2025 | -155.84 Mn |
| Mar 31, 2025 | -293.37 Mn |
| Dec 31, 2024 | -189.29 Mn |
| Sep 30, 2024 | -198.11 Mn |
| Jun 30, 2024 | -196.40 Mn |
| Mar 31, 2024 | -192.02 Mn |
| Dec 31, 2023 | -172.74 Mn |
| Sep 30, 2023 | -169.51 Mn |
| Jun 30, 2023 | -156.40 Mn |
| Mar 31, 2023 | -251.47 Mn |
| Dec 31, 2022 | -315.50 Mn |
| Sep 30, 2022 | -355.86 Mn |
| Jun 30, 2022 | -378.76 Mn |
| Mar 31, 2022 | -361.02 Mn |
| Dec 31, 2021 | -222.88 Mn |
| Sep 30, 2021 | -295.15 Mn |
| Jun 30, 2021 | -397.57 Mn |